> top > docs > PubMed:25733690 > annotations

PubMed:25733690 JSONTXT

Annnotations TAB JSON ListView MergeView

PubmedHPO

Id Subject Object Predicate Lexical cue
T1 231-248 HP_0002894 denotes pancreatic cancer
T2 242-248 HP_0002664 denotes cancer
T3 292-310 HP_0002894 denotes pancreatic cancers
T4 303-310 HP_0002664 denotes cancers
T5 380-386 HP_0002664 denotes tumors
T6 625-632 HP_0002664 denotes cancers
T7 705-712 HP_0000618 denotes blinded
T8 829-836 HP_0002664 denotes cancers
T9 946-953 HP_0002664 denotes cancers
T10 1035-1053 HP_0002894 denotes pancreatic cancers
T11 1046-1053 HP_0002664 denotes cancers
T12 1292-1298 HP_0002664 denotes tumors
T13 1623-1640 HP_0002894 denotes pancreatic cancer
T14 1634-1640 HP_0002664 denotes cancer
T15 1726-1743 HP_0002894 denotes pancreatic cancer
T16 1737-1743 HP_0002664 denotes cancer
T17 1886-1904 HP_0002894 denotes pancreatic cancers
T18 1897-1904 HP_0002664 denotes cancers

DisGeNET5_gene_disease

Id Subject Object Predicate Lexical cue
25733690-0#45#52#gene2526 45-52 gene2526 denotes lewis x
25733690-0#67#85#diseaseC0346647 67-85 diseaseC0346647 denotes pancreatic cancers
45#52#gene252667#85#diseaseC0346647 25733690-0#45#52#gene2526 25733690-0#67#85#diseaseC0346647 associated_with lewis x,pancreatic cancers

mondo_disease

Id Subject Object Predicate Lexical cue mondo_id
T1 67-85 Disease denotes pancreatic cancers http://purl.obolibrary.org/obo/MONDO_0005192|http://purl.obolibrary.org/obo/MONDO_0009831
T3 231-248 Disease denotes pancreatic cancer http://purl.obolibrary.org/obo/MONDO_0005192|http://purl.obolibrary.org/obo/MONDO_0009831
T5 292-310 Disease denotes pancreatic cancers http://purl.obolibrary.org/obo/MONDO_0005192|http://purl.obolibrary.org/obo/MONDO_0009831
T7 380-386 Disease denotes tumors http://purl.obolibrary.org/obo/MONDO_0005070
T8 1035-1053 Disease denotes pancreatic cancers http://purl.obolibrary.org/obo/MONDO_0005192|http://purl.obolibrary.org/obo/MONDO_0009831
T10 1069-1088 Disease denotes pancreatic diseases http://purl.obolibrary.org/obo/MONDO_0002356
T11 1292-1298 Disease denotes tumors http://purl.obolibrary.org/obo/MONDO_0005070
T12 1375-1396 Disease denotes ductal adenocarcinoma http://purl.obolibrary.org/obo/MONDO_0004953|http://purl.obolibrary.org/obo/MONDO_0005590
T14 1623-1640 Disease denotes pancreatic cancer http://purl.obolibrary.org/obo/MONDO_0005192|http://purl.obolibrary.org/obo/MONDO_0009831
T16 1726-1743 Disease denotes pancreatic cancer http://purl.obolibrary.org/obo/MONDO_0005192|http://purl.obolibrary.org/obo/MONDO_0009831
T18 1886-1904 Disease denotes pancreatic cancers http://purl.obolibrary.org/obo/MONDO_0005192|http://purl.obolibrary.org/obo/MONDO_0009831

GlyCosmos15-Glycan

Id Subject Object Predicate Lexical cue image
T1 38-52 Glycan denotes sialyl-lewis x https://api.glycosmos.org/wurcs2image/latest/png/binary/G00054MO
T2 108-122 Glycan denotes sialyl-lewis A https://api.glycosmos.org/wurcs2image/latest/png/binary/G00053MO
T3 128-142 Glycan denotes sialyl-Lewis A https://api.glycosmos.org/wurcs2image/latest/png/binary/G00053MO
T4 144-148 Glycan denotes sLeA https://api.glycosmos.org/wurcs2image/latest/png/binary/G00053MO
T5 371-375 Glycan denotes sLeA https://api.glycosmos.org/wurcs2image/latest/png/binary/G00053MO
T6 423-427 Glycan denotes sLeA https://api.glycosmos.org/wurcs2image/latest/png/binary/G00053MO
T7 548-552 Glycan denotes sLeA https://api.glycosmos.org/wurcs2image/latest/png/binary/G00053MO
T8 560-574 Glycan denotes sialyl-Lewis X https://api.glycosmos.org/wurcs2image/latest/png/binary/G00054MO
T9 576-580 Glycan denotes sLeX https://api.glycosmos.org/wurcs2image/latest/png/binary/G00054MO
T10 616-620 Glycan denotes sLeA https://api.glycosmos.org/wurcs2image/latest/png/binary/G00053MO
T11 799-803 Glycan denotes sLeX https://api.glycosmos.org/wurcs2image/latest/png/binary/G00054MO
T12 863-867 Glycan denotes sLeA https://api.glycosmos.org/wurcs2image/latest/png/binary/G00053MO
T13 897-901 Glycan denotes sLeA https://api.glycosmos.org/wurcs2image/latest/png/binary/G00053MO
T14 914-918 Glycan denotes sLeX https://api.glycosmos.org/wurcs2image/latest/png/binary/G00054MO
T15 937-941 Glycan denotes sLeA https://api.glycosmos.org/wurcs2image/latest/png/binary/G00053MO
T16 992-996 Glycan denotes sLeA https://api.glycosmos.org/wurcs2image/latest/png/binary/G00053MO
T17 1001-1005 Glycan denotes sLeX https://api.glycosmos.org/wurcs2image/latest/png/binary/G00054MO
T18 1172-1176 Glycan denotes sLeA https://api.glycosmos.org/wurcs2image/latest/png/binary/G00053MO
T19 1263-1267 Glycan denotes sLeX https://api.glycosmos.org/wurcs2image/latest/png/binary/G00054MO
T20 1326-1330 Glycan denotes sLeA https://api.glycosmos.org/wurcs2image/latest/png/binary/G00053MO
T21 1512-1516 Glycan denotes sLeA https://api.glycosmos.org/wurcs2image/latest/png/binary/G00053MO
T22 1521-1525 Glycan denotes sLeX https://api.glycosmos.org/wurcs2image/latest/png/binary/G00054MO

HP-phenotype

Id Subject Object Predicate Lexical cue hp_id
T1 67-85 Phenotype denotes pancreatic cancers HP:0002894
T2 231-248 Phenotype denotes pancreatic cancer HP:0002894
T3 292-310 Phenotype denotes pancreatic cancers HP:0002894
T4 1035-1053 Phenotype denotes pancreatic cancers HP:0002894
T5 1069-1088 Phenotype denotes pancreatic diseases HP:0001732
T6 1623-1640 Phenotype denotes pancreatic cancer HP:0002894
T7 1726-1743 Phenotype denotes pancreatic cancer HP:0002894
T8 1886-1904 Phenotype denotes pancreatic cancers HP:0002894

Glycan-GlyCosmos

Id Subject Object Predicate Lexical cue image
T1 45-52 Glycan denotes lewis x https://api.glycosmos.org/wurcs2image/latest/png/binary/G00051MO
T2 135-142 Glycan denotes Lewis A https://api.glycosmos.org/wurcs2image/latest/png/binary/G39023AU
T3 567-574 Glycan denotes Lewis X https://api.glycosmos.org/wurcs2image/latest/png/binary/G00051MO

GlyCosmos-GlycoEpitope

Id Subject Object Predicate Lexical cue glycoepitope_id
T1 38-52 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes sialyl-lewis x http://www.glycoepitope.jp/epitopes/EP0012
T2 128-142 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes sialyl-Lewis A http://www.glycoepitope.jp/epitopes/EP0008
T3 144-148 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes sLeA http://www.glycoepitope.jp/epitopes/EP0008
T4 371-375 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes sLeA http://www.glycoepitope.jp/epitopes/EP0008
T5 423-427 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes sLeA http://www.glycoepitope.jp/epitopes/EP0008
T6 548-552 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes sLeA http://www.glycoepitope.jp/epitopes/EP0008
T7 560-574 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes sialyl-Lewis X http://www.glycoepitope.jp/epitopes/EP0012
T8 576-580 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes sLeX http://www.glycoepitope.jp/epitopes/EP0012
T9 616-620 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes sLeA http://www.glycoepitope.jp/epitopes/EP0008
T10 799-803 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes sLeX http://www.glycoepitope.jp/epitopes/EP0012
T11 863-867 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes sLeA http://www.glycoepitope.jp/epitopes/EP0008
T12 897-901 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes sLeA http://www.glycoepitope.jp/epitopes/EP0008
T13 914-918 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes sLeX http://www.glycoepitope.jp/epitopes/EP0012
T14 937-941 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes sLeA http://www.glycoepitope.jp/epitopes/EP0008
T15 992-996 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes sLeA http://www.glycoepitope.jp/epitopes/EP0008
T16 1001-1005 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes sLeX http://www.glycoepitope.jp/epitopes/EP0012
T17 1172-1176 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes sLeA http://www.glycoepitope.jp/epitopes/EP0008
T18 1263-1267 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes sLeX http://www.glycoepitope.jp/epitopes/EP0012
T19 1326-1330 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes sLeA http://www.glycoepitope.jp/epitopes/EP0008
T20 1512-1516 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes sLeA http://www.glycoepitope.jp/epitopes/EP0008
T21 1521-1525 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes sLeX http://www.glycoepitope.jp/epitopes/EP0012

GlyCosmos15-HP

Id Subject Object Predicate Lexical cue hp_id
T1 67-85 Phenotype denotes pancreatic cancers HP:0002894
T2 231-248 Phenotype denotes pancreatic cancer HP:0002894
T3 292-310 Phenotype denotes pancreatic cancers HP:0002894
T4 1035-1053 Phenotype denotes pancreatic cancers HP:0002894
T5 1069-1088 Phenotype denotes pancreatic diseases HP:0001732
T6 1623-1640 Phenotype denotes pancreatic cancer HP:0002894
T7 1726-1743 Phenotype denotes pancreatic cancer HP:0002894
T8 1886-1904 Phenotype denotes pancreatic cancers HP:0002894

GlyCosmos15-Taxon

Id Subject Object Predicate Lexical cue db_id
T1 1469-1477 Organism denotes patients 9606
T2 1642-1648 Organism denotes Précis 311126
T3 1782-1790 Organism denotes patients 9606

GlyCosmos15-GlycoEpitope

Id Subject Object Predicate Lexical cue glycoepitope_id
T1 38-52 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes sialyl-lewis x http://www.glycoepitope.jp/epitopes/EP0012
T2 128-142 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes sialyl-Lewis A http://www.glycoepitope.jp/epitopes/EP0008
T3 144-148 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes sLeA http://www.glycoepitope.jp/epitopes/EP0008
T4 371-375 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes sLeA http://www.glycoepitope.jp/epitopes/EP0008
T5 423-427 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes sLeA http://www.glycoepitope.jp/epitopes/EP0008
T6 548-552 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes sLeA http://www.glycoepitope.jp/epitopes/EP0008
T7 560-574 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes sialyl-Lewis X http://www.glycoepitope.jp/epitopes/EP0012
T8 576-580 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes sLeX http://www.glycoepitope.jp/epitopes/EP0012
T9 616-620 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes sLeA http://www.glycoepitope.jp/epitopes/EP0008
T10 799-803 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes sLeX http://www.glycoepitope.jp/epitopes/EP0012
T11 863-867 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes sLeA http://www.glycoepitope.jp/epitopes/EP0008
T12 897-901 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes sLeA http://www.glycoepitope.jp/epitopes/EP0008
T13 914-918 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes sLeX http://www.glycoepitope.jp/epitopes/EP0012
T14 937-941 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes sLeA http://www.glycoepitope.jp/epitopes/EP0008
T15 992-996 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes sLeA http://www.glycoepitope.jp/epitopes/EP0008
T16 1001-1005 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes sLeX http://www.glycoepitope.jp/epitopes/EP0012
T17 1172-1176 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes sLeA http://www.glycoepitope.jp/epitopes/EP0008
T18 1263-1267 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes sLeX http://www.glycoepitope.jp/epitopes/EP0012
T19 1326-1330 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes sLeA http://www.glycoepitope.jp/epitopes/EP0008
T20 1512-1516 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes sLeA http://www.glycoepitope.jp/epitopes/EP0008
T21 1521-1525 http://purl.jp/bio/12/glyco/glycan#Glycan_epitope denotes sLeX http://www.glycoepitope.jp/epitopes/EP0012

GlyCosmos15-Sentences

Id Subject Object Predicate Lexical cue
T1 0-123 Sentence denotes Glycan motif profiling reveals plasma sialyl-lewis x elevations in pancreatic cancers that are negative for sialyl-lewis A.
T2 124-349 Sentence denotes The sialyl-Lewis A (sLeA) glycan forms the basis of the CA19-9 assay and is the current best biomarker for pancreatic cancer, but because it is not elevated in ∼25% of pancreatic cancers, it is not useful for early diagnosis.
T3 350-468 Sentence denotes We hypothesized that sLeA-low tumors secrete glycans that are related to sLeA but not detectable by CA19-9 antibodies.
T4 469-633 Sentence denotes We used a method called motif profiling to predict that a structural isomer of sLeA called sialyl-Lewis X (sLeX) is elevated in the plasma of some sLeA-low cancers.
T5 634-732 Sentence denotes We corroborated this prediction in a set of 48 plasma samples and in a blinded set of 200 samples.
T6 733-954 Sentence denotes An antibody sandwich assay formed by the capture and detection of sLeX was elevated in 13 of 69 cancers that were not elevated in sLeA, and a novel hybrid assay of sLeA capture and sLeX detected 24 of 69 sLeA-low cancers.
T7 955-1249 Sentence denotes A two-marker panel based on combined sLeA and sLeX detection differentiated 109 pancreatic cancers from 91 benign pancreatic diseases with 79% accuracy (74% sensitivity and 78% specificity), significantly better than sLeA alone, which yielded 68% accuracy (65% sensitivity and 71% specificity).
T8 1250-1397 Sentence denotes Furthermore, sLeX staining was evident in tumors that do not elevate plasma sLeA, including those with poorly differentiated ductal adenocarcinoma.
T9 1398-1478 Sentence denotes Thus, glycan-based biomarkers could characterize distinct subgroups of patients.
T10 1479-1641 Sentence denotes In addition, the combined use of sLeA and sLeX, or related glycans, could lead to a biomarker panel that is useful in the clinical diagnosis of pancreatic cancer.
T11 1642-1649 Sentence denotes Précis:
T12 1650-1905 Sentence denotes This paper shows that a structural isomer of the current best biomarker for pancreatic cancer, CA19-9, is elevated in the plasma of patients who are low in CA19-9, potentially enabling more comprehensive detection and classification of pancreatic cancers.

GlyCosmos15-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T1 67-85 Disease denotes pancreatic cancers MONDO:0005192|MONDO:0009831
T3 231-248 Disease denotes pancreatic cancer MONDO:0005192|MONDO:0009831
T5 292-310 Disease denotes pancreatic cancers MONDO:0005192|MONDO:0009831
T7 1035-1053 Disease denotes pancreatic cancers MONDO:0005192|MONDO:0009831
T9 1069-1088 Disease denotes pancreatic diseases MONDO:0002356
T10 1375-1396 Disease denotes ductal adenocarcinoma MONDO:0004953|MONDO:0005590
T12 1623-1640 Disease denotes pancreatic cancer MONDO:0005192|MONDO:0009831
T14 1726-1743 Disease denotes pancreatic cancer MONDO:0005192|MONDO:0009831
T16 1886-1904 Disease denotes pancreatic cancers MONDO:0005192|MONDO:0009831

GlyCosmos15-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T1 31-37 Body_part denotes plasma http://purl.obolibrary.org/obo/UBERON_0001969
T2 601-607 Body_part denotes plasma http://purl.obolibrary.org/obo/UBERON_0001969
T3 681-687 Body_part denotes plasma http://purl.obolibrary.org/obo/UBERON_0001969
T4 1319-1325 Body_part denotes plasma http://purl.obolibrary.org/obo/UBERON_0001969
T5 1772-1778 Body_part denotes plasma http://purl.obolibrary.org/obo/UBERON_0001969

GlyCosmos15-FMA

Id Subject Object Predicate Lexical cue db_id
T1 31-37 Body_part denotes plasma FMA:62970
T2 601-607 Body_part denotes plasma FMA:62970
T3 681-687 Body_part denotes plasma FMA:62970
T4 1319-1325 Body_part denotes plasma FMA:62970
T5 1772-1778 Body_part denotes plasma FMA:62970

NCBITAXON

Id Subject Object Predicate Lexical cue db_id
T1 1642-1648 OrganismTaxon denotes Précis 311126

Anatomy-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T1 31-37 Body_part denotes plasma http://purl.obolibrary.org/obo/UBERON_0001969
T2 601-607 Body_part denotes plasma http://purl.obolibrary.org/obo/UBERON_0001969
T3 681-687 Body_part denotes plasma http://purl.obolibrary.org/obo/UBERON_0001969
T4 1319-1325 Body_part denotes plasma http://purl.obolibrary.org/obo/UBERON_0001969
T5 1772-1778 Body_part denotes plasma http://purl.obolibrary.org/obo/UBERON_0001969